Cargando…
TOPCAT misses its primary endpoint: Should spironolactone be abandoned in HFpEF?
Heart failure with preserved ejection fraction (HFpEF) continues to be a challenging form of heart failure – one in which no therapy has yet been proven to improve outcome. Aldosterone antagonists have previously been shown to improve survival in a wide spectrum of patients with heart failure with r...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bloomsbury Qatar Foundation Journals
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991207/ https://www.ncbi.nlm.nih.gov/pubmed/24749108 http://dx.doi.org/10.5339/gcsp.2013.42 |